• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合门静脉和肝脏切除术治疗胆管癌

Combined portal vein and liver resection for carcinoma of the biliary tract.

作者信息

Nimura Y, Hayakawa N, Kamiya J, Maeda S, Kondo S, Yasui A, Shionoya S

机构信息

First Department of Surgery, Nagoya University School of Medicine, Japan.

出版信息

Br J Surg. 1991 Jun;78(6):727-31. doi: 10.1002/bjs.1800780629.

DOI:10.1002/bjs.1800780629
PMID:2070244
Abstract

Twenty-nine patients with advanced carcinoma of the bile duct or gallbladder underwent combined portal vein and liver resection. Segmental excision of the portal vein was performed in 16 cases and wedge resection of the vessel wall in 13. The operative mortality rate was 17 per cent. The median survival for the 24 patients who left hospital was 19.8 months. Actuarial survival rates at 1, 3 and 5 years for all 29 patients were 48 per cent, 29 per cent, and 6 per cent respectively, whereas the median survival for 46 patients with unresectable carcinoma was 3 months and the 1 and 3-year actuarial survival rates were 13 per cent and zero respectively. This difference in survival times between patients undergoing hepatectomy with portal vein resection and those with unresectable carcinoma were statistically significant (P less than 0.01). Combined portal vein and liver resection is recommended as a reasonable surgical approach in selected patients with advanced carcinoma of the biliary tract.

摘要

29例晚期胆管癌或胆囊癌患者接受了门静脉和肝脏联合切除术。16例行门静脉节段性切除,13例行血管壁楔形切除。手术死亡率为17%。24例出院患者的中位生存期为19.8个月。29例患者1年、3年和5年的精算生存率分别为48%、29%和6%,而46例不可切除癌患者的中位生存期为3个月,1年和3年的精算生存率分别为13%和0。接受门静脉切除肝切除术的患者与不可切除癌患者的生存时间差异具有统计学意义(P<0.01)。对于选定的晚期胆道癌患者,建议采用门静脉和肝脏联合切除术作为合理的手术方法。

相似文献

1
Combined portal vein and liver resection for carcinoma of the biliary tract.联合门静脉和肝脏切除术治疗胆管癌
Br J Surg. 1991 Jun;78(6):727-31. doi: 10.1002/bjs.1800780629.
2
Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder.肝切除联合门静脉或肝动脉重建治疗肝门部胆管癌和胆囊癌晚期。
World J Surg. 2003 Oct;27(10):1137-42. doi: 10.1007/s00268-003-6801-6. Epub 2003 Aug 21.
3
Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract.肝胰十二指肠切除术治疗晚期胆管癌
Hepatogastroenterology. 1991 Apr;38(2):170-5.
4
Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases.肝切除术联合门静脉和肝动脉切除治疗高位肝门部胆管癌:50 例连续病例的回顾性分析。
Ann Surg. 2010 Jul;252(1):115-23. doi: 10.1097/SLA.0b013e3181e463a7.
5
Indications for major hepatectomy and combined procedures for advanced gallbladder cancer.进展期胆囊癌行扩大肝切除术及联合脏器切除术的适应证。
Br J Surg. 2017 Feb;104(3):257-266. doi: 10.1002/bjs.10401. Epub 2016 Nov 16.
6
Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.两百四十例连续的在扩大肝切除术前进行的门静脉栓塞治疗胆管癌:手术结果及长期随访
Ann Surg. 2006 Mar;243(3):364-72. doi: 10.1097/01.sla.0000201482.11876.14.
7
Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor.胆道和胰腺癌手术中的门静脉切除:特别提及手术结果与原发肿瘤部位的关系。
J Gastrointest Surg. 2008 May;12(5):907-18. doi: 10.1007/s11605-007-0387-5. Epub 2007 Oct 30.
8
[Combined portal vein and liver resection for biliary cancer].[联合门静脉和肝脏切除术治疗胆管癌]
Nihon Geka Gakkai Zasshi. 2001 Nov;102(11):815-9.
9
Surgery of the portal vein in resection of cancer of the hepatic hilus.肝门部癌切除术中的门静脉手术
Surgery. 1986 Mar;99(3):344-9.
10
Portal vein resection and reconstruction prior to hepatic dissection during right hepatectomy and caudate lobectomy for hepatobiliary cancer.在针对肝胆癌的右半肝切除术和尾状叶切除术的肝解剖之前进行门静脉切除和重建。
Br J Surg. 2003 Jun;90(6):694-7. doi: 10.1002/bjs.4084.

引用本文的文献

1
Perihilar cholangiocarcinoma: a surgeon's perspective.肝门部胆管癌:外科医生的视角
ILIVER. 2022 Apr 5;1(1):12-24. doi: 10.1016/j.iliver.2022.03.004. eCollection 2022 Mar.
2
Essential updates 2021/2022: Update in surgical strategy for perihilar cholangiocarcinoma.2021/2022年重要更新:肝门部胆管癌手术策略的更新
Ann Gastroenterol Surg. 2023 Sep 8;7(6):848-855. doi: 10.1002/ags3.12734. eCollection 2023 Nov.
3
Research trends in cholangiocarcinoma treatments during the last 3 decades.过去三十年胆管癌治疗的研究趋势。
Heliyon. 2023 Jun 20;9(7):e17100. doi: 10.1016/j.heliyon.2023.e17100. eCollection 2023 Jul.
4
Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis.门静脉切除和肝动脉切除对 Klatskin 肿瘤患者长期生存的影响:一项荟萃分析。
World J Surg Oncol. 2022 Jul 12;20(1):230. doi: 10.1186/s12957-022-02692-1.
5
Vascular surgery in liver resection.肝切除术的血管外科处理。
Langenbecks Arch Surg. 2021 Nov;406(7):2217-2248. doi: 10.1007/s00423-021-02310-w. Epub 2021 Sep 14.
6
Fifty-year history of biliary surgery.胆道外科五十年史。
Ann Gastroenterol Surg. 2019 Sep 30;3(6):598-605. doi: 10.1002/ags3.12289. eCollection 2019 Nov.
7
Assessing resectability in cholangiocarcinoma.评估胆管癌的可切除性。
Hepat Oncol. 2014 Jan;1(1):39-51. doi: 10.2217/hep.13.6. Epub 2013 Dec 20.
8
Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis.吉西他滨辅助单药治疗可切除的伴淋巴结转移的肝门周围胆管癌:一项倾向评分匹配分析
Surg Today. 2017 Feb;47(2):182-192. doi: 10.1007/s00595-016-1354-0. Epub 2016 May 18.
9
Hepatic Artery Reconstruction with a Continuous Suture Method for Hepato-Biliary-Pancreatic Surgery.用于肝胆胰手术的连续缝合法肝动脉重建术
World J Surg. 2016 Apr;40(4):951-7. doi: 10.1007/s00268-015-3310-3.
10
Optimum chemotherapy for the management of advanced biliary tract cancer.晚期胆管癌治疗的最佳化疗方案。
World J Gastroenterol. 2015 Apr 14;21(14):4121-5. doi: 10.3748/wjg.v21.i14.4121.